Although a number of companies claim to sell "generic Daytrana" on the Internet, there is no generic version of Daytrana currently available. As a result of a legal settlement, a generic product could be introduced as early as September 2015. While methylphenidate is the active ingredient in Daytrana (and several other medications), it is not a generic form of it.
Daytrana™ (methylphenidate patch) is a prescription medication that has been licensed to treat attention deficit hyperactivity disorder (ADHD). Daytrana is a stimulant, although it has effects that are opposite from what would be expected of a stimulant. While stimulants (like caffeine) can cause hyperactivity, Daytrana has a calming effect when used at the proper doses.
Daytrana is manufactured by Noven Therapeutics. The medication is currently protected by a patent that prevents any generic Daytrana from being manufactured. Yet, if you search the Internet for "generic Daytrana," you may find a number of companies selling it. The fact is, these medicines are fake, substandard, and potentially dangerous. You should not buy any generic Daytrana until there is an approved generic available.
According to a settlement agreement between Noven Therapeutics (the maker of Daytrana) and Actavis (a generic manufacturer), generic Daytrana will likely be available starting in September 2015.
The answer is no. Methylphenidate is the active ingredient in Daytrana (and several other medications), but it is not a generic version of Daytrana. What can be confusing is that, often, the active ingredient of any drug is referred to as the "generic name" of the drug. The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off patent and another company besides the original manufacturer would make the product.